A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

PURPOSE: Neoadjuvant immunochemotherapy (nICT) for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) has attracted widespread attention recently, whose safety and clinical benefit was observed in clinical researches. This study aimed to develop and validate a novel predictor s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yalan, Xin, Dao, Wang, Huike, Guan, Lulu, Meng, Xiangrui, Lu, Taiying, Bai, Xiwen, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083012/
https://www.ncbi.nlm.nih.gov/pubmed/37042015
http://dx.doi.org/10.2147/JIR.S395231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083012/
https://www.ncbi.nlm.nih.gov/pubmed/37042015
http://dx.doi.org/10.2147/JIR.S395231

Ejemplares similares